marketcaparena
Search

    EYPT

    EyePoint, Inc.

    Company overview

    Market capitalization
    $285.36M
    Employees
    214
    Latest publication
    2026-09-29
    About EyePoint, Inc.

    EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue507,000USD696,000USD620,000USD966,000USD5,333,000USD24,453,000USD11,588,000USD10,524,000USD
    Research Development83,614,000USD72,148,000USD59,214,000USD47,754,000USD55,498,000USD58,574,000USD43,372,000USD29,542,000USD
    Selling And Marketing Expenses31,000USD3,000USD6,000USD26,000USD35,000USD35,000USD51,000USD24,000USD
    General And Administrative Expenses14,242,000USD———————
    Total Operating Expenses97,887,000USD87,394,000USD70,590,000USD62,270,000USD67,395,000USD72,485,000USD56,011,000USD42,536,000USD
    Operating Income-97,380,000USD-87,226,000USD-70,345,000USD-62,025,000USD-62,227,000USD-48,837,000USD-45,239,000USD-32,748,000USD
    Total Other Income Expense Net2,910,000USD2,344,000USD2,922,000USD2,293,000USD2,894,000USD3,642,000USD3,930,000USD3,387,000USD
    Income Before Tax-94,470,000USD-84,882,000USD-67,423,000USD-59,732,000USD-59,333,000USD-45,195,000USD-41,309,000USD-29,361,000USD
    Income Tax Expense0USD50,000USD-186,000USD—93,000USD—90,000USD—
    Net Income-94,470,000USD-84,832,000USD-67,609,000USD-59,732,000USD-59,426,000USD-45,195,000USD-41,399,000USD-29,361,000USD
    Cost Of Revenue—528,000USD375,000USD721,000USD165,000USD805,000USD816,000USD736,000USD
    Gross Profit—168,000USD245,000USD245,000USD5,168,000USD23,648,000USD10,772,000USD9,788,000USD
    Selling General Administrative—15,243,000USD11,382,000USD14,490,000USD11,862,000USD13,876,000USD12,588,000USD12,970,000USD
    Interest Income—2,344,000USD2,955,000USD2,293,000USD2,894,000USD3,642,000USD3,944,000USD3,387,000USD
    Net Interest Income—2,344,000USD2,922,000USD2,293,000USD2,894,000USD3,642,000USD3,930,000USD3,387,000USD
    Tax Provision—-50,000USD186,000USD0USD93,000USD0USD——
    Net Income From Continuing Ops—-84,832,000USD-67,609,000USD-59,732,000USD-59,426,000USD-45,195,000USD-41,399,000USD-29,361,000USD
    Ebit—-84,882,000USD-58,561,000USD-59,732,000USD-59,333,000USD-45,195,000USD-41,295,000USD-29,361,000USD
    Ebitda—-84,246,000USD-57,863,000USD-59,156,000USD-58,795,000USD-44,698,000USD-40,828,000USD-28,953,000USD
    Depreciation And Amortization—636,000USD698,000USD576,000USD538,000USD497,000USD467,000USD408,000USD
    Reconciled Depreciation—636,000USD698,000USD576,000USD538,000USD497,000USD467,000USD408,000USD
    Interest Expense——————14,000USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USD
    Total Revenue31,371,000USD7,539,000USD1,620,000USD26,565,000USD3,473,000USD2,143,000USD3,526,000USD4,965,000USD
    Cost Of Revenue2,066,000USD16,178,000USD14,880,000USD14,381,000USD78,000USD9,573,000USD7,005,000USD7,039,000USD
    Gross Profit29,305,000USD7,539,000USD1,620,000USD26,565,000USD3,395,000USD-7,430,000USD-3,479,000USD-2,074,000USD
    Research Development221,039,000USD14,880,000USD14,381,000USD12,088,000USD9,573,000USD7,005,000USD7,039,000USD6,864,000USD
    Selling General Administrative51,610,000USD11,235,000USD9,013,000USD8,056,000USD7,468,000USD7,169,000USD6,868,000USD8,104,000USD
    Selling And Marketing Expenses90,000USD———————
    Total Operating Expenses272,739,000USD26,115,000USD23,394,000USD20,144,000USD17,041,000USD14,174,000USD13,907,000USD14,968,000USD
    Operating Income-243,434,000USD-18,576,000USD-21,774,000USD6,421,000USD-13,490,000USD-12,031,000USD-25,211,000USD-10,003,000USD
    Interest Income11,784,000USD101,000USD91,000USD72,000USD————
    Interest Expense33,000USD720,000USD0USD0USD1,000USD2,000USD0USD1,000USD
    Net Interest Income11,751,000USD-619,000USD91,000USD72,000USD————
    Income Before Tax-231,683,000USD-18,485,000USD-21,702,000USD6,443,000USD-13,485,000USD-12,017,000USD-25,004,000USD-8,846,000USD
    Income Tax Expense279,000USD-815,000USD-155,000USD96,000USD-130,000USD-117,000USD-169,000USD-218,000USD
    Tax Provision279,000USD0USD0USD-155,000USD————
    Net Income-231,962,000USD-18,485,000USD-21,547,000USD6,347,000USD-13,355,000USD-11,900,000USD-24,835,000USD-8,628,000USD
    Net Income From Continuing Ops-231,962,000USD-53,171,000USD-18,485,000USD-21,547,000USD6,347,000USD-13,355,000USD-11,900,000USD-24,835,000USD
    Ebit-231,650,000USD-18,576,000USD-21,774,000USD6,421,000USD6,386,000USD-13,645,000USD-13,264,000USD-26,132,000USD
    Ebitda-229,341,000USD-17,761,000USD-20,866,000USD7,303,000USD7,303,000USD-12,651,000USD-11,037,000USD-22,777,000USD
    Depreciation And Amortization2,309,000USD815,000USD908,000USD882,000USD917,000USD994,000USD2,227,000USD3,355,000USD
    Reconciled Depreciation2,309,000USD1,148,000USD815,000USD—————
    Total Other Income Expense Net11,751,000USD91,000USD72,000USD3,000USD22,000USD5,000USD14,000USD207,000USD
    Non Operating Income Net Other—-26,177,000USD91,000USD75,000USD18,000USD5,000USD21,000USD207,000USD
    Net Income Applicable To Common Shares—-53,171,000USD-18,485,000USD-21,547,000USD6,347,000USD-13,355,000USD-11,900,000USD-24,835,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets228,191,000USD288,217,000USD363,996,000USD251,695,000USD301,147,000USD362,564,000USD418,465,000USD300,917,000USD
    Cash And Equivalents110,458,000USD———————
    Cash And Short Term Investments180,472,000USD222,545,000USD306,086,000USD204,022,000USD255,733,000USD318,194,000USD370,913,000USD253,793,000USD
    Short Term Investments70,014,000USD144,833,000USD204,265,000USD129,445,000USD184,590,000USD233,036,000USD271,209,000USD173,963,000USD
    Total Current Assets188,817,000USD249,504,000USD328,655,000USD216,106,000USD265,251,000USD326,983,000USD383,306,000USD268,549,000USD
    Other Current Assets6,377,000USD24,552,000USD20,105,000USD8,929,000USD6,215,000USD6,218,000USD9,481,000USD11,571,000USD
    Other Non Current Assets9,368,000USD———————
    Total Liabilities61,780,000USD———————
    Total Current Liabilities41,943,000USD37,460,000USD37,024,000USD30,094,000USD33,175,000USD41,677,000USD49,048,000USD48,794,000USD
    Other Current Liabilities2,679,000USD———————
    Other Non Current Liabilities23,000USD———————
    Total Stockholder Equity166,411,000USD230,472,000USD306,113,000USD200,182,000USD246,009,000USD298,396,000USD336,501,000USD218,734,000USD
    Total Equity Including Noncontrolling Interest166,411,000USD———————
    Net Receivables86,000USD1,157,000USD651,000USD1,045,000USD625,000USD442,000USD607,000USD378,000USD
    Inventory1,882,000USD1,250,000USD1,813,000USD2,110,000USD2,678,000USD2,129,000USD2,305,000USD2,807,000USD
    Property Plant Equipment Net29,856,000USD19,777,000USD20,223,000USD29,521,000USD21,089,000USD29,554,000USD29,177,000USD29,796,000USD
    Accounts Payable17,267,000USD18,813,000USD10,490,000USD10,076,000USD19,685,000USD16,419,000USD11,721,000USD7,343,000USD
    Common Stock85,000USD83,000USD83,000USD70,000USD69,000USD69,000USD68,000USD53,000USD
    Retained Earnings-1,284,280,000USD-1,189,810,000USD-1,104,978,000USD-1,037,369,000USD-977,637,000USD-918,211,000USD-873,016,000USD-831,617,000USD
    Accumulated Other Comprehensive Income793,000USD802,000USD961,000USD919,000USD832,000USD923,000USD1,028,000USD1,171,000USD
    Total Liab—57,745,000USD57,883,000USD51,513,000USD55,138,000USD64,168,000USD81,964,000USD82,183,000USD
    Other Current Liab—16,563,000USD24,512,001USD18,057,000USD13,490,000USD18,375,000USD19,543,000USD15,455,000USD
    Capital Stock—83,000USD83,000USD70,000USD69,000USD69,000USD68,000USD53,000USD
    Cash—77,712,000USD101,821,000USD74,577,000USD71,143,000USD85,158,000USD99,704,000USD79,830,000USD
    Net Debt—-55,398,000USD-79,027,001USD-51,315,000USD-49,328,000USD-61,076,000USD-77,846,000USD-57,908,000USD
    Short Term Debt—2,084,000USD2,021,999USD1,961,000USD—1,768,000USD1,247,000USD1,289,000USD
    Short Long Term Debt Total—22,314,000USD22,793,999USD23,262,000USD21,815,000USD24,082,000USD21,858,000USD21,922,000USD
    Property Plant Equipment Gross—29,259,000USD35,263,000USD29,521,000USD29,851,000USD29,554,000USD33,234,000USD29,796,000USD
    Common Stock Shares Outstanding—85,999,000shares83,031,000shares70,168,000shares69,926,000shares69,767,000shares64,556,000shares54,449,000shares
    Non Current Assets Total—38,712,999USD35,341,000USD35,589,000USD35,896,000USD35,581,000USD35,159,000USD32,368,000USD
    Non Current Liabilities Total—20,284,999USD20,859,000USD21,419,000USD21,963,000USD22,491,000USD32,916,000USD33,389,000USD
    Non Current Liabilities Other—55,000USD87,000USD118,000USD148,000USD177,000USD205,000USD233,000USD
    Non Currrent Assets Other—18,935,999USD15,118,000USD6,068,000USD14,807,000USD6,027,000USD5,982,000USD2,572,000USD
    Net Working Capital—212,044,000USD291,631,000USD186,012,000USD232,076,000USD285,306,000USD334,258,000USD219,755,000USD
    Unclassified Non Current Liabilities—20,229,999USD20,772,000USD21,301,000USD21,815,000USD22,314,000USD32,711,000USD33,156,000USD
    Unclassified Equity—1,419,314,000USD1,409,964,000USD1,236,492,000USD1,222,676,000USD1,215,546,000USD1,208,353,000USD1,049,074,000USD
    Current Deferred Revenue—————5,115,000USD17,784,000USD25,996,000USD
    Unclassified Current Liabilities——————-1,247,000USD-1,289,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets363,996,000USD418,465,000USD355,184,000USD180,356,000USD263,372,000USD91,717,000USD72,971,000USD71,670,000USD
    Other Current Assets20,105,000USD9,481,000USD9,039,000USD9,858,000USD4,217,000USD3,419,000USD5,997,000USD1,133,000USD
    Total Liab57,883,000USD81,964,000USD88,861,000USD83,988,000USD78,992,000USD73,176,000USD64,641,000USD59,983,000USD
    Total Stockholder Equity306,113,000USD336,501,000USD266,323,000USD96,368,000USD184,380,000USD18,541,000USD8,330,000USD11,687,000USD
    Other Current Liab24,512,001USD19,543,000USD18,167,000USD16,359,000USD14,422,000USD687,000USD6,832,000USD15,000,000USD
    Common Stock83,000USD68,000USD49,000USD34,000USD34,000USD528,380,000USD11,000USD374,840,000USD
    Capital Stock83,000USD68,000USD49,000USD34,000USD34,000USD18,000USD109,000USD—
    Retained Earnings-1,104,978,000USD-873,016,000USD-742,146,000USD-671,351,000USD-569,097,000USD-510,680,000USD-465,286,000USD-363,991,000USD
    Cash101,821,000USD99,704,000USD281,263,000USD95,633,000USD178,593,000USD44,909,000USD22,214,000USD38,776,000USD
    Cash And Short Term Investments306,086,000USD370,913,000USD331,050,000USD144,561,000USD211,558,000USD44,909,000USD22,214,000USD38,776,000USD
    Total Current Assets328,655,000USD383,306,000USD344,800,000USD172,808,000USD237,745,000USD63,118,000USD41,717,000USD39,909,000USD
    Total Current Liabilities37,024,000USD49,048,000USD63,263,000USD34,537,000USD23,658,000USD14,888,000USD11,520,000USD21,663,000USD
    Net Debt-79,027,001USD-77,846,000USD-276,357,000USD-49,285,000USD-139,389,000USD-4,602,000USD28,388,000USD-21,467,000USD
    Short Term Debt2,021,999USD1,247,000USD563,000USD11,054,000USD782,000USD8,445,000USD481,000USD30,000USD
    Short Long Term Debt Total22,793,999USD21,858,000USD4,906,000USD46,348,000USD39,204,000USD46,422,000USD50,602,000USD17,651,000USD
    Short Term Investments204,265,000USD271,209,000USD49,787,000USD48,928,000USD32,965,000USD0USD——
    Net Receivables651,000USD607,000USD805,000USD15,503,000USD18,354,000USD9,453,000USD11,368,000USD353,000USD
    Inventory1,813,000USD2,305,000USD3,906,000USD2,886,000USD3,616,000USD5,337,000USD2,138,000USD-353,000USD
    Accounts Payable10,490,000USD11,721,000USD6,504,000USD5,919,000USD7,385,000USD4,811,000USD4,192,000USD6,663,000USD
    Property Plant Equipment Net20,223,000USD29,177,000USD10,234,000USD7,398,000USD2,728,000USD3,240,000USD3,435,000USD253,000USD
    Property Plant Equipment Gross35,263,000USD33,234,000USD12,805,000USD6,038,000USD2,252,000USD3,240,000USD3,435,000USD253,000USD
    Accumulated Other Comprehensive Income961,000USD1,028,000USD864,000USD786,000USD841,000USD841,000USD840,000USD838,000USD
    Common Stock Shares Outstanding73,251,000shares56,298,000shares38,904,000shares37,317,000shares28,758,000shares12,836,000shares10,430,700shares4,622,600shares
    Non Current Assets Total35,341,000USD35,159,000USD10,384,000USD7,548,000USD25,627,000USD28,599,000USD31,254,000USD31,761,000USD
    Non Current Liabilities Total20,859,000USD32,916,000USD25,598,000USD49,451,000USD55,334,000USD58,288,000USD53,121,000USD38,320,000USD
    Non Current Liabilities Other87,000USD205,000USD—6,584,000USD4,212,000USD4,695,000USD5,898,000USD—
    Non Currrent Assets Other15,118,000USD5,982,000USD150,000USD150,000USD150,000USD150,000USD150,000USD150,000USD
    Net Working Capital291,631,000USD334,258,000USD281,537,000USD138,271,000USD214,087,000USD48,230,000USD30,197,000USD—
    Unclassified Non Current Liabilities20,772,000USD32,711,000USD25,598,000USD-14,157,000USD-16,912,000USD-17,981,000USD-3,000,000USD19,244,000USD
    Unclassified Equity1,409,964,000USD1,208,353,000USD1,007,507,000USD766,865,000USD752,568,000USD—472,656,000USD—
    Current Deferred Revenue—17,784,000USD38,592,000USD1,205,000USD1,069,000USD945,000USD15,000USD30,000USD
    Unclassified Current Liabilities—-1,247,000USD—-10,475,000USD————
    Deferred Long Term Liab———13,557,000USD14,560,000USD15,616,000USD——
    Other Liab———14,157,000USD16,912,000USD17,981,000USD3,000,000USD1,455,000USD
    Other Assets———150,000USD626,000USD150,000USD150,000USD150,000USD
    Short Long Term Debt———10,475,000USD————
    Long Term Debt———29,310,000USD36,562,000USD37,977,000USD47,223,000USD17,621,000USD
    Net Tangible Assets———96,368,000USD161,631,000USD-6,668,000USD-19,339,000USD7,504,000USD
    Intangible Assets————22,749,000USD25,209,000USD27,669,000USD31,358,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-84,832,000USD-67,609,000USD-59,732,000USD-59,426,000USD-45,195,000USD-41,399,000USD-29,361,000USD-30,826,000USD
    Depreciation636,000USD698,000USD576,000USD538,000USD497,000USD467,000USD408,000USD362,000USD
    Stock Based Compensation11,638,000USD6,749,000USD6,428,000USD6,876,000USD7,820,000USD7,900,000USD7,446,000USD8,695,000USD
    Other Non Cash Items-778,000USD-1,033,000USD-861,000USD-1,291,000USD-1,733,000USD-1,720,000USD-28,552,000USD-1,692,000USD
    Change To Account Receivables-4,954,000USD-10,781,000USD-3,134,000USD-180,000USD3,428,000USD1,863,000USD-939,000USD3,092,000USD
    Change To Inventory563,000USD297,000USD568,000USD-549,000USD176,000USD502,000USD865,000USD584,000USD
    Change In Working Capital-7,213,000USD-4,311,000USD-5,675,000USD-9,286,000USD-14,509,000USD-1,097,000USD11,031,000USD3,283,000USD
    Total Cash From Operating Activities-80,549,000USD-65,047,000USD-59,354,000USD-62,589,000USD-53,120,000USD-35,849,000USD-39,028,000USD-20,178,000USD
    Capital Expenditures-997,000USD-986,000USD-798,000USD-1,220,000USD-276,000USD-384,000USD-1,574,000USD-900,000USD
    Free Cash Flow-81,546,000USD-66,033,000USD-60,152,000USD-63,809,000USD-53,396,000USD-36,233,000USD-40,602,000USD-21,078,000USD
    Investments60,051,000USD-73,835,000USD55,385,000USD48,336,000USD39,525,000USD-95,962,000USD16,196,000USD-160,395,000USD
    Total Cashflows From Investing Activities59,054,000USD-74,666,000USD55,385,000USD48,336,000USD39,525,000USD-95,962,000USD16,196,000USD-160,395,000USD
    Net Borrowings-29,000USD-27,000USD-27,000USD-16,000USD-35,000USD-32,000USD-73,000USD—
    Total Cash From Financing Activities-2,614,000USD166,957,000USD7,403,000USD238,000USD-951,000USD151,685,000USD11,893,000USD329,000USD
    Change In Cash-24,109,000USD27,244,000USD3,434,000USD-14,015,000USD-14,546,000USD19,874,000USD-10,939,000USD-180,244,000USD
    Begin Period Cash Flow101,821,000USD74,727,000USD71,293,000USD85,308,000USD99,704,000USD79,980,000USD90,769,000USD271,013,000USD
    End Period Cash Flow77,712,000USD101,971,000USD74,727,000USD71,293,000USD85,158,000USD99,854,000USD79,980,000USD90,769,000USD
    Other Cashflows From Investing Activities778,000USD-3,569,000USD3,885,000USD———4,143,000USD-159,495,000USD
    Other Cashflows From Financing Activities-3,713,000USD273,000USD-133,000USD-19,000USD-1,509,000USD-365,000USD12,044,000USD-296,000USD
    Unclassified Financing Cash Flow1,128,000USD—7,563,000USD—————
    Issuance Of Capital Stock—166,787,000USD———151,521,000USD——
    Unclassified Investing Cash Flow—3,724,000USD-3,087,000USD1,220,000USD——-2,569,000USD160,395,000USD
    Sale Purchase Of Stock——————-78,000USD-78,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-231,962,000USD-130,870,000USD-70,795,000USD-102,254,000USD-58,417,000USD-45,394,000USD-56,793,000USD-53,171,000USD
    Depreciation2,309,000USD1,540,000USD464,000USD2,446,000USD2,771,000USD2,649,000USD2,604,000USD1,148,000USD
    Stock Based Compensation27,873,000USD36,740,000USD12,057,000USD14,177,000USD7,447,000USD5,547,000USD4,568,000USD3,967,000USD
    Other Non Cash Items-4,828,000USD-5,953,000USD1,184,000USD23,649,000USD628,000USD1,722,000USD1,648,000USD209,000USD
    Change To Account Receivables-10,667,000USD-244,000USD14,432,000USD-2,662,000USD-10,603,000USD4,846,000USD-15,304,000USD7,000USD
    Change To Inventory492,000USD1,600,000USD-1,553,000USD-760,000USD1,347,000USD-3,200,000USD-1,859,000USD-759,000USD
    Change In Working Capital-33,781,000USD-27,773,000USD58,882,000USD-3,023,000USD-1,739,000USD20,136,000USD-12,536,000USD925,000USD
    Total Cash From Operating Activities-240,110,000USD-126,226,000USD1,875,000USD-65,005,000USD-50,097,000USD-14,435,000USD-56,699,000USD-21,907,000USD
    Capital Expenditures-3,280,000USD-4,052,000USD-3,483,000USD-2,150,000USD-156,000USD-362,000USD-213,000USD-108,000USD
    Free Cash Flow-243,390,000USD-130,278,000USD-1,608,000USD-67,155,000USD-50,253,000USD-14,797,000USD-56,912,000USD-22,015,000USD
    Investments71,705,000USD-219,355,000USD-3,315,000USD-15,115,000USD-32,965,000USD-362,000USD-213,000USD-32,965,000USD
    Total Cashflows From Investing Activities68,580,000USD-219,355,000USD-3,315,000USD-17,265,000USD-33,121,000USD-362,000USD-213,000USD-16,888,000USD
    Net Borrowings-105,000USD-105,000USD-40,511,000USD-653,000USD-146,000USD-14,622,000USD25,943,000USD20,000,000USD
    Total Cash From Financing Activities173,647,000USD164,022,000USD187,070,000USD-690,000USD216,902,000USD37,492,000USD33,864,000USD60,671,000USD
    Issuance Of Capital Stock173,445,000USD163,314,000USD226,174,000USD108,476,000USD216,825,000USD49,918,000USD22,627,000USD—
    Change In Cash2,117,000USD-181,559,000USD185,630,000USD-82,960,000USD133,684,000USD22,695,000USD-23,047,000USD21,878,000USD
    Begin Period Cash Flow99,854,000USD281,413,000USD95,633,000USD178,743,000USD45,059,000USD22,364,000USD45,411,000USD17,048,000USD
    End Period Cash Flow101,971,000USD99,854,000USD281,263,000USD95,783,000USD178,743,000USD45,059,000USD22,364,000USD38,926,000USD
    Other Cashflows From Investing Activities4,828,000USD5,953,000USD168,000USD558,000USD-32,965,000USD———
    Other Cashflows From Financing Activities-1,388,000USD813,000USD1,407,000USD-2,498,000USD223,000USD-624,000USD-18,763,000USD-20,195,000USD
    Unclassified Investing Cash Flow-4,673,000USD—3,315,000USD—32,965,000USD——16,185,000USD
    Sale Purchase Of Stock——-169,000USD-295,000USD-150,000USD-90,000USD-120,000USD-195,000USD
    Unclassified Financing Cash Flow——226,343,000USD2,756,000USD216,975,000USD52,828,000USD26,804,000USD61,061,000USD
    Change To Liabilities———1,198,000USD7,545,000USD1,872,000USD4,596,000USD1,980,000USD
    Cash And Cash Equivalents Changes———-82,960,000USD133,684,000USD22,695,000USD-23,048,000USD—
    Unclassified Operating Cash Flow——————3,810,000USD25,015,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductLicense And Collaboration Agreement507,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct0USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct Rights Agreement0USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty0USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductLicense And Collaboration Agreement88,000USD0001193125-26-211870
    Q1 2026Quarterly · 2026-03-31ProductProduct467,000USD0001193125-26-211870
    Q1 2026Quarterly · 2026-03-31ProductProduct Rights Agreement0USD0001193125-26-211870
    Q1 2026Quarterly · 2026-03-31ProductRoyalty141,000USD0001193125-26-211870
    Q1 2026Quarterly · 2026-03-31ProductRoyalty Purchase Agreement0USD0001193125-26-211870
    FY 2025Yearly · 2025-12-31GeographyChina1,292,000USD0001193125-26-093917
    FY 2025Yearly · 2025-12-31GeographyUnited Kingdom100,000USD0001193125-26-093917
    FY 2025Yearly · 2025-12-31GeographyUnited States29,979,000USD0001193125-26-093917
    FY 2024Yearly · 2024-12-31GeographyChina1,124,000USD0001193125-26-093917
    FY 2024Yearly · 2024-12-31GeographyUnited Kingdom100,000USD0001193125-26-093917
    FY 2024Yearly · 2024-12-31GeographyUnited States42,049,000USD0001193125-26-093917
    FY 2023Yearly · 2023-12-31GeographyChina648,000USD0000950170-25-034601
    FY 2023Yearly · 2023-12-31GeographyUnited Kingdom100,000USD0000950170-25-034601
    FY 2023Yearly · 2023-12-31GeographyUnited States45,270,000USD0000950170-25-034601
    Q1 2023Quarterly · 2023-03-31ProductCollaborative Research And Development0USD0000950170-23-017724
    Q1 2023Quarterly · 2023-03-31ProductLicense And Collaboration Agreement34,000USD0000950170-23-017724
    Q1 2023Quarterly · 2023-03-31ProductOther255,000USD0000950170-23-017724
    Q1 2023Quarterly · 2023-03-31ProductProduct7,394,000USD0000950170-23-017724
    Q1 2023Quarterly · 2023-03-31ProductProduct Sales License And Collaboration Revenue Or Royalty Income0USD0000950170-23-017724
    FY 2022Yearly · 2022-12-31GeographyChina823,000USD0000950170-24-028523
    FY 2022Yearly · 2022-12-31GeographyUnited Kingdom100,000USD0000950170-24-028523
    FY 2022Yearly · 2022-12-31GeographyUnited States40,481,000USD0000950170-24-028523
    Q3 2022Quarterly · 2022-09-30ProductCollaborative Research And Development0USD0000950170-22-022141
    Q3 2022Quarterly · 2022-09-30ProductDEXYCUProduct2,447,000USD0000950170-22-022141
    Q3 2022Quarterly · 2022-09-30ProductLicense And Collaboration Agreement52,000USD0000950170-22-022141
    Q3 2022Quarterly · 2022-09-30ProductLicense And Collaboration Revenue50,000USD0000950170-22-022141
    Q3 2022Quarterly · 2022-09-30ProductOther190,000USD0000950170-22-022141
    Q3 2022Quarterly · 2022-09-30ProductYUTIQProduct7,273,000USD0000950170-22-022141
    Q2 2022Quarterly · 2022-06-30ProductCollaborative Research And Development0USD0000950170-22-015071
    Q2 2022Quarterly · 2022-06-30ProductDEXYCUProduct3,897,000USD0000950170-22-015071
    Q2 2022Quarterly · 2022-06-30ProductOther247,000USD0000950170-22-015071
    Q2 2022Quarterly · 2022-06-30ProductYUTIQProduct7,421,000USD0000950170-22-015071
    Q1 2022Quarterly · 2022-03-31ProductCollaborative Research And Development0USD0000950170-23-017724
    Q1 2022Quarterly · 2022-03-31ProductLicense And Collaboration Agreement59,000USD0000950170-23-017724
    Q1 2022Quarterly · 2022-03-31ProductOther225,000USD0000950170-23-017724
    Q1 2022Quarterly · 2022-03-31ProductProduct9,010,000USD0000950170-23-017724
    Q1 2022Quarterly · 2022-03-31ProductProduct Sales License And Collaboration Revenue Or Royalty Income0USD0000950170-23-017724
    FY 2021Yearly · 2021-12-31GeographyChina851,000USD0000950170-23-007180
    FY 2021Yearly · 2021-12-31GeographyUnited Kingdom100,000USD0000950170-23-007180
    FY 2021Yearly · 2021-12-31GeographyUnited States35,988,000USD0000950170-23-007180
    Q3 2021Quarterly · 2021-09-30ProductCollaborative Research And Development0USD0000950170-22-022141
    Q3 2021Quarterly · 2021-09-30ProductDEXYCUProduct4,659,000USD0000950170-22-022141
    Q3 2021Quarterly · 2021-09-30ProductLicense And Collaboration Agreement159,000USD0000950170-22-022141
    Q3 2021Quarterly · 2021-09-30ProductLicense And Collaboration Revenue78,000USD0000950170-22-022141
    Q3 2021Quarterly · 2021-09-30ProductOther235,000USD0000950170-22-022141
    Q3 2021Quarterly · 2021-09-30ProductYUTIQProduct3,928,000USD0000950170-22-022141
    Q2 2021Quarterly · 2021-06-30ProductCollaborative Research And Development0USD0000950170-22-015071
    Q2 2021Quarterly · 2021-06-30ProductDEXYCUProduct4,572,000USD0000950170-22-015071
    Q2 2021Quarterly · 2021-06-30ProductLicense And Collaboration Agreement94,000USD0000950170-22-015071
    Q2 2021Quarterly · 2021-06-30ProductLicense And Collaboration Revenue91,000USD0000950170-22-015071
    Q2 2021Quarterly · 2021-06-30ProductOther90,000USD0000950170-22-015071
    Q2 2021Quarterly · 2021-06-30ProductYUTIQProduct4,166,000USD0000950170-22-015071
    FY 2020Yearly · 2020-12-31GeographyChina11,713,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31GeographyUnited Kingdom100,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31GeographyUnited States22,624,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductCollaborative Research And Development255,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductDEXYCUProduct6,953,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductLicense And Collaboration Agreement11,942,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductRoyalty1,664,000USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductRoyalty Purchase Agreement0USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductTechnology Service0USD0001564590-22-009929
    FY 2020Yearly · 2020-12-31ProductYUTIQProduct13,878,000USD0001564590-22-009929
    FY 2019Yearly · 2019-12-31GeographyChina1,121,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31GeographyUnited Kingdom100,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31GeographyUnited States19,144,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31ProductCollaborative Research And Development135,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31ProductDEXYCUProduct4,778,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31ProductLicense And Collaboration Agreement1,361,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31ProductRoyalty2,180,000USD0001564590-21-012894
    FY 2019Yearly · 2019-12-31ProductYUTIQProduct12,046,000USD0001564590-21-012894
    FY 2018Yearly · 2018-12-31ProductCollaborative Research And Development2,625,000USD0001564590-20-010956
    FY 2018Yearly · 2018-12-31ProductRoyalty1,946,000USD0001564590-20-010956
    FY 2018Yearly · 2018-06-30GeographyUnited Kingdom100,000USD0001564590-20-010956
    FY 2018Yearly · 2018-06-30GeographyUnited States2,861,000USD0001564590-20-010956
    FY 2017Yearly · 2017-06-30ProductCollaborative Research And Development6,569,000USD0001193125-18-276414
    FY 2017Yearly · 2017-06-30ProductRoyalty970,000USD0001193125-18-276414
    FY 2016Yearly · 2016-06-30ProductCollaborative Research And Development398,000USD0001193125-18-276414
    FY 2016Yearly · 2016-06-30ProductRoyalty1,222,000USD0001193125-18-276414

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.